Compare BMA & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMA | IRTC |
|---|---|---|
| Founded | 1966 | 2006 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2006 | 2016 |
| Metric | BMA | IRTC |
|---|---|---|
| Price | $81.95 | $125.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $96.75 | ★ $197.92 |
| AVG Volume (30 Days) | 279.6K | ★ 380.8K |
| Earning Date | 05-27-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $747,138,000.00 |
| Revenue This Year | $16.25 | $19.60 |
| Revenue Next Year | N/A | $15.94 |
| P/E Ratio | $33.22 | ★ N/A |
| Revenue Growth | N/A | ★ 26.24 |
| 52 Week Low | $38.30 | $97.16 |
| 52 Week High | $106.15 | $210.01 |
| Indicator | BMA | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 60.76 | 55.26 |
| Support Level | $64.88 | $119.48 |
| Resistance Level | $94.54 | $165.84 |
| Average True Range (ATR) | 3.37 | 4.80 |
| MACD | 1.12 | 1.76 |
| Stochastic Oscillator | 90.25 | 85.93 |
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.